register

Medical

Medical researchers support interim budget measures and urge longer-term sustainability

Health Industry Hub | September 28, 2020 |

Medical News: The $700 million bail-out package for university researchers flagged for consideration in the upcoming federal budget would be critical to maintaining Australia’s national health and medical research capability.

Research Australia CEO, Nadia Levin said, “More than half of all Australian health and medical research in Australia is undertaken in the higher education sector. This research is at risk due to the loss of university revenue from international students. Health and medical research is a critical national capability and it must be protected, for its role in saving lives, improving our health system and our post-pandemic economic recovery.”

A Government commitment to supporting universities and research jobs would be a welcome interim step towards establishing a more sustainable higher education sector.

“In the long term, we need to look at effective partnerships between higher education, government, industry and philanthropy. It’s clear that Australia can no longer rely so heavily on international student fees to subsidise research.

“The package mooted in today’s Australian would give the universities some breathing room to consider a longer-term plan for funding research.” Nadia Levin said.

“Immediate measures are needed to provide job security for Australian health and medical researchers. Currently, half the health and medical researchers in this country are employed on short-term contracts. This rises to two thirds of early career researchers.

“Compare this to the broader Australian population where only 5.2% of people with permanent employment are employed on fixed term contracts. It’s easy to see why Australia runs the very real risk of losing a generation of early and mid-career health and medical researchers without some immediate intervention and more focus on long-term sustainability.”

As the national peak body for Australian health and medical research, Research Australia is working with its members from all stages of health and medical research to encourage a united position on research funding.

“We can’t just rely on government funding or international student fees, it is going to need to be a combined effort with industry, philanthropy and the health system. Working together, we’re confident Australia can become a world-leader in health and medical research, generating new STEM jobs and advanced manufacturing industries which will drive post-pandemic economic recovery.”


ESG

Landmark National Health and Climate Strategy to roll out 'green procurement guidelines' for medicines and surgical supplies

Landmark National Health and Climate Strategy to roll out ‘green procurement guidelines’ for medicines and surgical supplies

Health Industry Hub | December 5, 2023 |

ESG: At the 28th United Nations Climate Conference (COP28) in Dubai, Ged Kearney MP, Assistant Minister for Health and Aged […]

More


News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

Health Industry Hub | December 5, 2023 |

Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]

More


News & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Health Industry Hub | December 5, 2023 |

MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]

More


News & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?

Does the evidence support safety concerns following CAR-T cell therapies?

Health Industry Hub | December 5, 2023 |

Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]

More


This content is copyright protected. Please subscribe to gain access.